https://www.ft.com/content/bf99e9e3-d104-4a92-81a1-8bd70b884b3f
SVB Leerink Maintains Market Perform on Enanta Pharmaceuticals, Raises Price Target to $92
SVB Leerink analyst Roanna Ruiz maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Market Perform and raises the price target from $55 to $92.